Myriad Genetics Stock Drops Sharply After Hours: What Investors Need to Know
Myriad Genetics Inc. (NASDAQ: MYGN ) shares plunged 37.80% in Thursday’s after-hours session after the company reported second-quarter 2026 financial results that included lower revenue, an operating loss, reduced full-year revenue guidance and the suspension of its adjusted EBITDA outlook. The stock closed Thursday’s